Measuring Growth and Evaluating Pubertal Development in Pediatric Clinical Trials; Draft Guidance for Industry; Availability
Detailed guidance document from FDA and regulatory agencies.
Document Details
Guidance Document
October 31, 2022
April 11, 2024
b3766e09-0a47-4099-a69c-f48ac2979eb8
Related Documents
Pediatric Drug Development Under the Pediatric Research Equity Act and the Best Pharmaceuticals for Children Act: Scientific Considerations
Guidance DocumentMay 17, 2023Center for Drug Evaluation and Research
Early Alzheimer’s Disease: Developing Drugs for Treatment
Guidance DocumentMarch 12, 2024Center for Drug Evaluation and Research
Pregnant Women: Scientific and Ethical Considerations for Inclusion in Clinical Trials
Guidance DocumentApril 9, 2018Center for Drug Evaluation and Research
Quick Actions
Transform Regulatory Data into Actionable Intelligence
Join leading pharmaceutical and medical device companies who trust GKS for their regulatory compliance needs.
Try KeyPedia Today
Explore our real use cases and discover our features in depth.
Subscribe to our newsletter
Get the latest updates and insights delivered to your inbox